Last reviewed · How we verify

NCT04894513

Electro Physiological Responses to Kabat Motor Control Re-education on Bell's Palsy: A Randomized Controlled Study

Completed NA Last updated 9 August 2021
What this trial tests

NA trial testing Kabat motor control re-education therapy in Facial Nerve Palsy in 30 participants. Completed in 30 May 2021.

Timeline
15 February 2021
Primary endpoint
15 May 2021
30 May 2021

Quick facts

Lead sponsorLama Saad El-Din Mahmoud
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date15 February 2021
Primary completion15 May 2021
Estimated completion30 May 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Lama Saad El-Din Mahmoud

Who can join

Adults 12 to 16, any sex, with Facial Nerve Palsy or Bell's Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the Effect of Kabat motor control re-education therapy on facial nerve Electro physiological responses and facial muscles function in bell's palsy. BACKGROUND: facial nerve recovery in children could be improved through facilitation of nerve regeneration which can be enhanced through Kabat motor control re-education therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Electrophysiological responses to Kabat motor control re-education on Bell's Palsy: A randomized controlled study.
    Hamed SA, Saad El-Din Mahmoud L, Magdy ElMeligie M, Zoheiry IM. · · 2023 · cited 1× · PMID 36856104

Verify or expand the search:

Other recruiting trials for Facial Nerve Palsy

Currently open trials in the same condition.

Other Lama Saad El-Din Mahmoud trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04894513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing